The Cardiovascular Prevention Program
Recruiting
N/A
Interventional Study
Cardiovascular Prevention
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 30
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 150 (estimated)
- Sponsor
- Maria Cecilia Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Cardiovascular diseases represent one of the main public health problems being the leading cause of morbidity, disability and mortality. In recent decades, the global prevalence and cardiovascular disease mortality has increased, with 23.6 million annual deaths expected by 2030. In Europe, mortality per year is equal to 2.2 million women and 1.9 million men, representing 47% and 37% of all deaths …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* primary prevention: age ≥ 30 years with a negative history of cardiovascular events
* secondary prevention: age ≥ 30 years with a negative history of cardiovascular events
Exclusion Criteria:
* severe obesity
* high-grade renal failure
* severe and/or dialysis
* oncological …
Contacts